QID 731142

Date Published: 2024-02-08

QID 731142: Liferay Portal Stored Cross-Site Scripting (XSS) Vulnerability (CVE-2024-25145)

Liferay Portal is an open-source enterprise web platform for building business solutions and collaborative applications.

CVE-2024-25145: Stored cross-site scripting (XSS) vulnerability found in the Portal Search module's Search Result app in Liferay Portal.

Affected Versions:
Liferay Portal from version 7.4.0 to 7.4.3.11.
Liferay Portal from version 7.3.0 to 7.3.7.
Liferay Portal, older unsupported versions.

QID Detection Logic (Unauthenticated):
This QID checks for vulnerable versions of Liferay Portal in the response banner.

Successful exploitation of this vulnerability allows remote authenticated users to inject arbitrary web script or HTML into the Search Result app's search result if highlighting is disabled by adding any searchable content (e.g., blog, message board message, web content article) to the application.

CVSS V3 rated as Medium - 5.4 severity.

CVSS V2 rated as Critical - 10 severity.

Solution

Vendor has released patch. For more info, please refer to Liferay Portal Security Advisory

Vendor References

Liferay Portal - liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/cve-2024-25145

CVEs related to QID 731142

CVE-2024-25145 |

Software Advisories

Advisory ID	Software	Component	Link
CVE-2024-25145			liferay.dev/portal/security/known-vulnerabilities/-/asset_publisher/jekt/content/cve-2024-25145

By selecting these links, you may be leaving CVEreport webspace. We have provided these links to other websites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other websites that are more appropriate for your purpose. CVEreport does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, CVEreport does not endorse any commercial products that may be mentioned on these sites. Please address comments about any linked pages to [email protected].